Janus Henderson Group PLC reduced its stake in Innospec Inc. (NASDAQ:IOSP - Free Report) by 16.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 463,411 shares of the specialty chemicals company's stock after selling 90,810 shares during the period. Janus Henderson Group PLC owned 1.86% of Innospec worth $52,406,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of IOSP. Allspring Global Investments Holdings LLC boosted its position in shares of Innospec by 4.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,405,770 shares of the specialty chemicals company's stock worth $272,069,000 after purchasing an additional 105,311 shares in the last quarter. Wasatch Advisors LP boosted its position in Innospec by 0.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,805,546 shares of the specialty chemicals company's stock worth $204,189,000 after purchasing an additional 11,231 shares in the last quarter. Victory Capital Management Inc. grew its position in Innospec by 4.8% during the third quarter. Victory Capital Management Inc. now owns 908,032 shares of the specialty chemicals company's stock valued at $102,689,000 after buying an additional 41,449 shares during the period. Royce & Associates LP increased its stake in shares of Innospec by 9.3% in the 3rd quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company's stock valued at $94,468,000 after purchasing an additional 70,902 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Innospec by 3.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 336,522 shares of the specialty chemicals company's stock valued at $38,057,000 after buying an additional 11,479 shares in the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Innospec from a "strong-buy" rating to a "buy" rating in a report on Thursday, August 8th.
Read Our Latest Report on Innospec
Insider Activity at Innospec
In related news, Director Milton C. Blackmore sold 1,035 shares of the stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total transaction of $127,222.20. Following the sale, the director now owns 9,028 shares of the company's stock, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.52% of the stock is currently owned by insiders.
Innospec Stock Down 0.8 %
NASDAQ IOSP traded down $0.98 on Friday, reaching $116.16. The stock had a trading volume of 70,232 shares, compared to its average volume of 108,932. Innospec Inc. has a 12-month low of $103.97 and a 12-month high of $133.71. The stock has a fifty day moving average price of $115.03 and a two-hundred day moving average price of $118.08. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 20.44 and a beta of 1.09.
Innospec (NASDAQ:IOSP - Get Free Report) last issued its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, meeting the consensus estimate of $1.35. The firm had revenue of $443.40 million for the quarter, compared to analysts' expectations of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The firm's revenue was down 4.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.59 earnings per share. Sell-side analysts forecast that Innospec Inc. will post 5.88 earnings per share for the current fiscal year.
Innospec Increases Dividend
The business also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were given a dividend of $0.79 per share. This represents a yield of 1.3%. This is a boost from Innospec's previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend was Monday, November 18th. Innospec's dividend payout ratio (DPR) is presently 27.57%.
About Innospec
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.